Literature DB >> 16757065

Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination.

M A Almuneef1, Z A Memish, H H Balkhy, M Qahtani, B Alotaibi, A Hajeer, L Qasim, B Al Knawy.   

Abstract

This study aims to determine the seroprevalence of Hepatitis A among a selected group of Saudi children and thus, identify the best immunization strategy. A school-based seroprevalence study in children 4-18 years of age attending the National Guard schools was done. Of the 25,531 children attending the National Guard schools, 2399 (10%) were randomly selected through a stratified one-stage cluster survey. The overall prevalence of HAV-IgG was 28.9%. The prevalence was almost the same in male and female (28.2% versus 29.5%, respectively). There was a gradual increase in the HAV-IgG with 7% in children (< 8 years), 14% (8-11 years), 30% (12-15 years), and 52% (> 16 years) of age. Since a substantial proportion of this pediatric population confirms a continuing decrease in anti-HAV seroconversion rates, we recommend including Hepatitis A in the schedule of routine childhood vaccinations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757065     DOI: 10.1016/j.vaccine.2006.04.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Authors:  Eduardo Lazcano-Ponce; Carlos Conde-Gonzalez; Rosalba Rojas; Rodrigo DeAntonio; Luis Romano-Mazzotti; Yolanda Cervantes; Eduardo Ortega-Barria
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

2.  Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years.

Authors:  Faleh Al Faleh; Suliman Al Shehri; Saleh Al Ansari; Mohammed Al Jeffri; Yaqoub Al Mazrou; Ahmad Shaffi; Ayman-A Abdo
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

3.  Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review.

Authors:  Mohammed Jafar Saffar; Omid Abedian; Abolghasem Ajami; Farshideh Abedian; Araz Mohammad Mirabi; Ali-Reza Khalilian; Hana Saffar
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

Review 4.  Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.

Authors:  Ziba Farajzadegan; Shervin Ghaffari Hoseini; Roya Kelishadi; Fahimeh Jamshidi; Zari Nokhodian; Rasool Noori; Parisa Mirmoghtadaee; Silva Hovsepian; Seyyed-Nassereddin Mostafavi
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852

5.  Prevalence of G6PD deficiency in Children with Hepatitis A.

Authors:  Ghasem Miri-Aliabad; Ali Khajeh; Tooran Shahraki
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

6.  Evidence of Circulation of Several HAV Genetic Variants and Emergence of Potential Antigenic Variants in an Endemo-Epidemic Country before Vaccine Introduction.

Authors:  Kaouther Ayouni; Anissa Chouikha; Oussema Khamessi; Henda Touzi; Walid Hammemi; Henda Triki
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

Review 7.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

Review 8.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.